{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:10Z","timestamp":1793726470648,"version":"4.6.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004410","name":"TUBITAK","doi-asserted-by":"crossref","award":["218S569"],"award-info":[{"award-number":["218S569"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05419-x","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:01:44Z","timestamp":1763366504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the Rho\/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson\u2019s Disease, Both In Vivo and In Vitro"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5330-6159","authenticated-orcid":false,"given":"Ebru","family":"Guclu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4505-0760","authenticated-orcid":false,"given":"Salim Yalcin","family":"Inan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3796-575X","authenticated-orcid":false,"given":"Canan Eroglu","family":"Gunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-7807","authenticated-orcid":false,"given":"Hasibe","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"2","key":"5419_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH (2015) Mitochondrial dysfunction in Parkinson\u2019s disease. Exp Neurobiol 24(2):103\u2013116. https:\/\/doi.org\/10.5607\/en.2015.24.2.103","journal-title":"Exp Neurobiol"},{"issue":"8","key":"5419_CR2","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/bph.12433","volume":"171","author":"I Celardo","year":"2014","unstructured":"Celardo I, Martins LM, Gandhi S (2014) Unravelling mitochondrial pathways to Parkinson\u2019s disease. Br J Pharmacol 171(8):1943\u20131957. https:\/\/doi.org\/10.1111\/bph.12433","journal-title":"Br J Pharmacol"},{"key":"5419_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1498756","volume":"16","author":"Y Luo","year":"2021","unstructured":"Luo Y, Qiao L, Li M, Wen X, Zhang W, Li X (2021) Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the global burden of disease study 2021. Front Aging Neurosci 16:1498756. https:\/\/doi.org\/10.3389\/fnagi.2024.1498756","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"5419_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/s1471-4914(03)00020-0","volume":"9","author":"A Barzilai","year":"2003","unstructured":"Barzilai A, Melamed E (2003) Molecular mechanisms of selective dopaminergic neuronal death in Parkinson\u2019s disease. Trends Mol Med 9(3):126\u2013132. https:\/\/doi.org\/10.1016\/s1471-4914(03)00020-0","journal-title":"Trends Mol Med"},{"issue":"3","key":"5419_CR5","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s12035-017-0496-4","volume":"55","author":"R Siracusa","year":"2018","unstructured":"Siracusa R, Paterniti I, Cordaro M, Crupi R, Bruschetta G, Campolo M et al (2018) Neuroprotective effects of temsirolimus in animal models of Parkinson\u2019s disease. Mol Neurobiol 55(3):2403\u20132419. https:\/\/doi.org\/10.1007\/s12035-017-0496-4","journal-title":"Mol Neurobiol"},{"key":"5419_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/35086062","volume":"2","author":"E Bezard","year":"2001","unstructured":"Bezard E, Brotchie JM, Gross CE (2001) Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2:577\u2013588. https:\/\/doi.org\/10.1038\/35086062","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"5419_CR7","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s10787-024-01510-2","volume":"32","author":"D Soni","year":"2024","unstructured":"Soni D, Upadhayay S, Dhureja M, Arthur R, Kumar P (2024) Crosstalk between gut-brain axis: unveiling the mysteries of gut ROS in progression of Parkinson\u2019s disease. Inflammopharmacology 32(5):2921\u20132941. https:\/\/doi.org\/10.1007\/s10787-024-01510-2","journal-title":"Inflammopharmacology"},{"issue":"2","key":"5419_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11064-025-04369-z","volume":"50","author":"S Upadhayay","year":"2025","unstructured":"Upadhayay S, Uttam V, Kumar P (2025) G-protein-coupled estrogen receptor 1 (GPER1) activation mitigates haloperidol-induced neurotoxicity in SHSY-5Y cells and improves motor functions in adult zebrafish. Neurochem Res 50(2):119. https:\/\/doi.org\/10.1007\/s11064-025-04369-z","journal-title":"Neurochem Res"},{"issue":"1","key":"5419_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11064-024-04319-1","volume":"50","author":"M Aqeel","year":"2025","unstructured":"Aqeel M, Upadhayay S, Devi R, Jangid K, Kumar V, Kumar P (2025) Glycyrrhizic acid mitigates haloperidol-induced neurotoxicity in SHSY-5Y cells and rats via activation of PI3k\/Akt\/Nrf2 pathways. Neurochem Res 50(1):75. https:\/\/doi.org\/10.1007\/s11064-024-04319-1","journal-title":"Neurochem Res"},{"key":"5419_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-019-0080-x","volume":"5","author":"KJ Billingsley","year":"2019","unstructured":"Billingsley KJ, Barbosa IA, Bandr\u00e9s-Ciga S, Quinn JP, Bubb VJ, Deshpande C et al (2019) Mitochondria function associated genes contribute to Parkinson\u2019s disease risk and later age at onset. NPJ Parkinsons Dis 5:8. https:\/\/doi.org\/10.1038\/s41531-019-0080-x","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"5419_CR11","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s10571-020-01027-6","volume":"42","author":"FM de Ara\u00fajo","year":"2022","unstructured":"de Ara\u00fajo FM, Cuenca-Bermejo L, Fern\u00e1ndez-Villalba E, Costa SL, Silva VDA, Herrero MT (2022) Role of microgliosis and NLRP3 inflammasome in Parkinson\u2019s disease pathogenesis and therapy. Cell Mol Neurobiol 42(5):1283\u20131300. https:\/\/doi.org\/10.1007\/s10571-020-01027-6","journal-title":"Cell Mol Neurobiol"},{"key":"5419_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mito.2019.07.003","volume":"49","author":"Y Wu","year":"2019","unstructured":"Wu Y, Chen M, Jiang J (2019) Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion 49:35\u201345. https:\/\/doi.org\/10.1016\/j.mito.2019.07.003","journal-title":"Mitochondrion"},{"key":"5419_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.615461","volume":"8","author":"J Prasuhn","year":"2021","unstructured":"Prasuhn J, Davis RL, Kumar KR (2021) Targeting mitochondrial impairment in Parkinson\u2019s disease: challenges and opportunities. Front Cell Dev Biol 8:615461. https:\/\/doi.org\/10.3389\/fcell.2020.615461","journal-title":"Front Cell Dev Biol"},{"key":"5419_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00314","volume":"8","author":"TR Stankiewicz","year":"2014","unstructured":"Stankiewicz TR, Linseman DA (2014) Rho family GTPases: key players in neuronal development, neuronal survival, and neurodegeneration. Front Cell Neurosci 8:314. https:\/\/doi.org\/10.3389\/fncel.2014.00314","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"5419_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCRESAHA.115.306532","volume":"118","author":"H Shimokawa","year":"2016","unstructured":"Shimokawa H, Sunamura S, Satoh K (2016) RhoA\/Rho-kinase in the cardiovascular system. Circ Res 118(2):352\u2013366. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306532","journal-title":"Circ Res"},{"issue":"1","key":"5419_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1006\/excr.2000.5046","volume":"261","author":"M Amano","year":"2000","unstructured":"Amano M, Fukata Y, Kaibuchi K (2000) Regulation and functions of Rho-associated kinase. Exp Cell Res 261(1):44\u201351. https:\/\/doi.org\/10.1006\/excr.2000.5046","journal-title":"Exp Cell Res"},{"issue":"2","key":"5419_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1006\/bbrc.1999.1409","volume":"263","author":"R Hashimoto","year":"1999","unstructured":"Hashimoto R, Nakamura Y, Kosako H, Amano M, Kaibuchi K, Inagaki M et al (1999) Distribution of Rho-kinase in the bovine brain. Biochem Biophys Res Commun 263(2):575\u2013579. https:\/\/doi.org\/10.1006\/bbrc.1999.1409","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"5419_CR18","first-page":"5324","volume":"11","author":"Z Deng","year":"2019","unstructured":"Deng Z, Jia Y, Liu H, He M, Yang Y, Xiao W et al (2019) Rhoa\/ROCK pathway: implication in osteoarthritis and therapeutic targets. Am J Transl Res 11(9):5324\u20135331","journal-title":"Am J Transl Res"},{"issue":"5","key":"5419_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrd1719","volume":"4","author":"BK Mueller","year":"2005","unstructured":"Mueller BK, Mack H, Teusch N (2005) Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 4(5):387\u2013398. https:\/\/doi.org\/10.1038\/nrd1719","journal-title":"Nat Rev Drug Discov"},{"issue":"24","key":"5419_CR20","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1002\/elps.201200470","volume":"33","author":"M Raad","year":"2012","unstructured":"Raad M, El Tal T, Gul R, Mondello S, Zhang Z, Boustany RM et al (2012) Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma. Electrophoresis 33(24):3659\u20133668. https:\/\/doi.org\/10.1002\/elps.201200470","journal-title":"Electrophoresis"},{"issue":"49","key":"5419_CR21","doi-asserted-by":"publisher","first-page":"19086","DOI":"10.1523\/JNEUROSCI.2508-13.2013","volume":"33","author":"JH Herskowitz","year":"2013","unstructured":"Herskowitz JH, Feng Y, Mattheyses AL, Hales CM, Higginbotham LA, Duong DM et al (2013) Pharmacologic inhibition of ROCK2 suppresses amyloid-\u03b2 production in an Alzheimer\u2019s disease mouse model. J Neurosci 33(49):19086\u201319098. https:\/\/doi.org\/10.1523\/JNEUROSCI.2508-13.2013","journal-title":"J Neurosci"},{"issue":"2","key":"5419_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/bph.12277","volume":"170","author":"M Takata","year":"2013","unstructured":"Takata M, Tanaka H, Kimura M, Nagahara Y, Tanaka K, Kawasaki K et al (2013) Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis. Br J Pharmacol 170(2):341\u2013351. https:\/\/doi.org\/10.1111\/bph.12277","journal-title":"Br J Pharmacol"},{"key":"5419_CR23","doi-asserted-by":"publisher","unstructured":"Shan S, Su M, Wang H, Guo F, Li Y, Zhou Y, Liu H, Du L, et al. (2024) Y-27632 targeting ROCK1&2 modulates cell growth, fibrosis and epithelial-mesenchymal transition in hyperplastic prostate by inhibiting \u03b2-catenin pathway. Mol Biomed 5(1):52. https:\/\/doi.org\/10.1186\/s43556-024-00216-9","DOI":"10.1186\/s43556-024-00216-9"},{"issue":"4","key":"5419_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/toxres\/tfaf088","volume":"14","author":"H Jiang","year":"2025","unstructured":"Jiang H, Jin L, Tan S, Huang H, Li Y, Fu G, Yan J (2025) Combined treatment with mesenchymal stem cells and ROCK inhibitor Y-27632 ameliorates PM2.5-induced lung injury. Toxicol Res 14(4):tfaf088. https:\/\/doi.org\/10.1093\/toxres\/tfaf088","journal-title":"Toxicol Res"},{"issue":"1","key":"5419_CR25","doi-asserted-by":"publisher","first-page":"9763","DOI":"10.1038\/s41598-024-60239-8","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y, Gao G, Han Y, Xiao B, Shen L, Yang X, Liu Y, Mu Y, et al. (2024) Rho kinase inhibitor Y-27632 downregulates IL-1\u03b2 expression in mice with experimental autoimmune myocarditis. Sci Rep 14(1):9763. https:\/\/doi.org\/10.1038\/s41598-024-60239-8","journal-title":"Sci Rep"},{"key":"5419_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.858069","volume":"13","author":"A Rodr\u00edguez-Trillo","year":"2022","unstructured":"Rodr\u00edguez-Trillo A, Pena C, Garc\u00eda S, P\u00e9rez-Pamp\u00edn E, Rodr\u00edguez-L\u00f3pez M, Mera-Varela A, Gonz\u00e1lez A, Conde C (2022) Rock inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis. Front Immunol 13:858069. https:\/\/doi.org\/10.3389\/fimmu.2022.858069","journal-title":"Front Immunol"},{"issue":"3","key":"5419_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.nbd.2009.06.011","volume":"36","author":"M Li","year":"2009","unstructured":"Li M, Huang Y, Ma AA, Lin E, Diamond MI (2009) Y-27632 improves rotarod performance and reduces huntingtin levels in R6\/2 mice. Neurobiol Dis 36(3):413\u2013420. https:\/\/doi.org\/10.1016\/j.nbd.2009.06.011","journal-title":"Neurobiol Dis"},{"issue":"3","key":"5419_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12640-012-9339-2","volume":"23","author":"BT Jeon","year":"2013","unstructured":"Jeon BT, Jeong EA, Park SY, Son H, Shin HJ, Lee DH, Kim HJ, Kang SS et al (2013) The Rho-kinase (ROCK) inhibitor Y-27632 protects against excitotoxicity-induced neuronal death in vivo and in vitro. Neurotoxicity Res 23(3):238\u2013248. https:\/\/doi.org\/10.1007\/s12640-012-9339-2","journal-title":"Neurotoxicity Res"},{"issue":"1","key":"5419_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/toxsci\/kfq114","volume":"116","author":"TJ Chen","year":"2010","unstructured":"Chen TJ, Hung HS, Wang DC, Chen SS (2010) The protective effect of Rho-associated kinase inhibitor on aluminum-induced neurotoxicity in rat cortical neurons. Toxicol Sci 116(1):264\u2013272. https:\/\/doi.org\/10.1093\/toxsci\/kfq114","journal-title":"Toxicol Sci"},{"issue":"4","key":"5419_CR30","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s11011-016-9820-3","volume":"31","author":"SY Inan","year":"2016","unstructured":"Inan SY, Soner BC, Sahin AS (2016) Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson\u2019s disease. Metab Brain Dis 31(4):849\u2013857. https:\/\/doi.org\/10.1007\/s11011-016-9820-3","journal-title":"Metab Brain Dis"},{"key":"5419_CR31","doi-asserted-by":"publisher","first-page":"7148","DOI":"10.1523\/JNEUROSCI.14-11-07148.1994","volume":"14","author":"EI Miklyaeva","year":"1994","unstructured":"Miklyaeva EI, Castaneda E, Whishaw IQ (1994) Skilled reaching deficits in unilateral dopamine-depleted rats: impairments in movement and posture and compensatory adjustments. J Neurosci 14:7148\u20137158. https:\/\/doi.org\/10.1523\/JNEUROSCI.14-11-07148.1994","journal-title":"J Neurosci"},{"key":"5419_CR32","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, San Diego","edition":"4"},{"key":"5419_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-201x.1971.tb11000.x","volume":"367","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69\u201393. https:\/\/doi.org\/10.1111\/j.1365-201x.1971.tb11000.x","journal-title":"Acta Physiol Scand Suppl"},{"key":"5419_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","volume":"24","author":"U Ungerstedt","year":"1970","unstructured":"Ungerstedt U, Arbuthnott GW (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24:485\u2013493. https:\/\/doi.org\/10.1016\/0006-8993(70)90187-3","journal-title":"Brain Res"},{"key":"5419_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1006\/exnr.1998.6848","volume":"152","author":"D Kirik","year":"1998","unstructured":"Kirik D, Rosenblad C, Bjorklund A (1998) Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152:259\u2013277. https:\/\/doi.org\/10.1006\/exnr.1998.6848","journal-title":"Exp Neurol"},{"issue":"12","key":"5419_CR36","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1523\/JNEUROSCI.20-12-04686.2000","volume":"20","author":"D Kirik","year":"2000","unstructured":"Kirik D, Rosenblad C, Bjorklund A, Mandel RJ (2000) Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson\u2019s model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci 20(12):4686\u20134700. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-12-04686.2000","journal-title":"J Neurosci"},{"issue":"5","key":"5419_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/s0028-3908(00)00005-8","volume":"39","author":"T Schallert","year":"2000","unstructured":"Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39(5):777\u2013787. https:\/\/doi.org\/10.1016\/s0028-3908(00)00005-8","journal-title":"Neuropharmacology"},{"key":"5419_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bbr.2012.02.034","volume":"231","author":"SM Fleming","year":"2012","unstructured":"Fleming SM, Schallert T, Ciucci MR (2012) Cranial and related sensorimotor impairments in rodent models of Parkinson\u2019s disease. Behav Brain Res 231:317\u2013322. https:\/\/doi.org\/10.1016\/j.bbr.2012.02.034","journal-title":"Behav Brain Res"},{"key":"5419_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbr.2011.12.007","volume":"230","author":"KE Glajch","year":"2012","unstructured":"Glajch KE, Fleming SM, Surmeier DJ, Osten P (2012) Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson\u2019s disease. Behav Brain Res 230:309\u2013316. https:\/\/doi.org\/10.1016\/j.bbr.2011.12.007","journal-title":"Behav Brain Res"},{"issue":"2","key":"5419_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jneumeth.2005.04.023","volume":"151","author":"ME Sughrue","year":"2006","unstructured":"Sughrue ME, Mocco J, Komotar RJ, Mehra A, D\u2019Ambrosio AL, Grobelny BT et al (2006) An improved test of neurological dysfunction following transient focal cerebral ischemia in rats. J Neurosci Methods 151(2):83\u201389. https:\/\/doi.org\/10.1016\/j.jneumeth.2005.04.023","journal-title":"J Neurosci Methods"},{"key":"5419_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2022.105458","volume":"84","author":"E G\u00fc\u00e7l\u00fc","year":"2022","unstructured":"G\u00fc\u00e7l\u00fc E, \u00c7\u0131nar Ayan \u0130, Dursun HG, Vural H (2022) Tomentosin induces apoptosis in pancreatic cancer cells through increasing reactive oxygen species and decreasing mitochondrial membrane potential. Toxicol In Vitro 84:105458. https:\/\/doi.org\/10.1016\/j.tiv.2022.105458","journal-title":"Toxicol In Vitro"},{"key":"5419_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1385\/1-59259-867-6:013","volume":"297","author":"S K\u00f6chl","year":"2005","unstructured":"K\u00f6chl S, Niederst\u00e4tter H, Parson W (2005) DNA extraction and quantitation of forensic samples using the phenol-chloroform method and real-time PCR. Methods Mol Biol 297:13\u201330. https:\/\/doi.org\/10.1385\/1-59259-867-6:013","journal-title":"Methods Mol Biol"},{"issue":"9","key":"5419_CR43","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.7150\/thno.109071","volume":"15","author":"M Xia","year":"2025","unstructured":"Xia M, Li C, Chen J, Wu C, Zhang J, Hong H, Jiang J, Xu G, et al. (2025) Activation of FANCC attenuates mitochondrial ROS-driven necroptosis by targeting TBK1-dependent mitophagy in astrocytes after spinal cord injury. Theranostics 15(9):4188\u20134211. https:\/\/doi.org\/10.7150\/thno.109071","journal-title":"Theranostics"},{"issue":"11","key":"5419_CR44","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1007\/s12035-022-03026-8","volume":"59","author":"E Guclu","year":"2022","unstructured":"Guclu E, Inan SY, Vural HC (2022) The sirtuin 2 inhibitor AK-7 leads to an antidepressant-like effect in mice via upregulation of CREB1, BDNF, and NTRK2 pathways. Mol Neurobiol 59(11):7036\u20137044. https:\/\/doi.org\/10.1007\/s12035-022-03026-8","journal-title":"Mol Neurobiol"},{"issue":"Pt 1","key":"5419_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/brain\/awm260","volume":"131","author":"S Petratos","year":"2008","unstructured":"Petratos S, Li QX, George AJ, Hou X, Kerr ML, Unabia SE et al (2008) The beta-amyloid protein of Alzheimer\u2019s disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 131(Pt 1):90\u2013108. https:\/\/doi.org\/10.1093\/brain\/awm260","journal-title":"Brain"},{"issue":"9","key":"5419_CR46","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/tx300171u","volume":"25","author":"JH Chen","year":"2012","unstructured":"Chen JH, Ou HP, Lin CY, Lin FJ, Wu CR, Chang SW et al (2012) Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis. Chem Res Toxicol 25(9):1893\u20131901. https:\/\/doi.org\/10.1021\/tx300171u","journal-title":"Chem Res Toxicol"},{"key":"5419_CR47","first-page":"1727","volume":"18","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Quantock AJ, Young RD, Okumura N, Ueno M, Sakamoto Y et al (2012) A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma. Mol Vis 18:1727\u20131739","journal-title":"Mol Vis"},{"issue":"2","key":"5419_CR48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/jnc.12383","volume":"127","author":"K Saadipour","year":"2013","unstructured":"Saadipour K, Yang M, Lim Y, Georgiou K, Sun Y, Keating D et al (2013) Amyloid beta\u2081\u208b\u2084\u2082 (A\u03b2\u2084\u2082) up-regulates the expression of sortilin via the p75(NTR)\/RhoA signaling pathway. J Neurochem 127(2):152\u2013162. https:\/\/doi.org\/10.1111\/jnc.12383","journal-title":"J Neurochem"},{"issue":"1","key":"5419_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13287-015-0008-2","volume":"6","author":"Z Li","year":"2015","unstructured":"Li Z, Han S, Wang X, Han F, Zhu X, Zheng Z et al (2015) Rho kinase inhibitor Y-27632 promotes the differentiation of human bone marrow mesenchymal stem cells into keratinocyte-like cells in xeno-free conditioned medium. Stem Cell Res Ther 6(1):17. https:\/\/doi.org\/10.1186\/s13287-015-0008-2","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"5419_CR50","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","volume":"15","author":"A Elkouzi","year":"2019","unstructured":"Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS (2019) Emerging therapies in Parkinson disease - repurposed drugs and new approaches. Nat Rev Neurol 15(4):204\u2013223. https:\/\/doi.org\/10.1038\/s41582-019-0155-7","journal-title":"Nat Rev Neurol"},{"key":"5419_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/JIR.S232009","volume":"13","author":"Z Geto","year":"2020","unstructured":"Geto Z, Molla MD, Challa F, Belay Y, Getahun T (2020) Mitochondrial dynamic dysfunction as a main triggering factor for inflammation associated chronic non-communicable diseases. J Inflamm Res 13:97\u2013107. https:\/\/doi.org\/10.2147\/JIR.S232009","journal-title":"J Inflamm Res"},{"issue":"3","key":"5419_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1017\/s0317167100014232","volume":"40","author":"MM Lewis","year":"2013","unstructured":"Lewis MM, Galley S, Johnson S, Stevenson J, Huang X, McKeown MJ (2013) The role of the cerebellum in the pathophysiology of Parkinson\u2019s disease. Can J Neurol Sci 40(3):299\u2013306. https:\/\/doi.org\/10.1017\/s0317167100014232","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"5419_CR53","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.parkreldis.2014.12.030","volume":"21","author":"YX Gui","year":"2015","unstructured":"Gui YX, Xu ZP, Lv W, Zhao JJ, Hu XY (2015) Evidence for polymerase gamma, POLG1 variation in reduced mitochondrial DNA copy number in Parkinson\u2019s disease. Parkinsonism Relat Disord 21(3):282\u2013286. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.12.030","journal-title":"Parkinsonism Relat Disord"},{"key":"5419_CR54","doi-asserted-by":"publisher","first-page":"216.e7","DOI":"10.1016\/j.neurobiolaging.2015.10.033","volume":"38","author":"A Pyle","year":"2016","unstructured":"Pyle A, Anugrha H, Kurzawa-Akanbi M, Yarnall A, Burn D, Hudson G (2016) Reduced mitochondrial DNA copy number is a biomarker of Parkinson\u2019s disease. Neurobiol Aging 38:216.e7-216.e10. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.10.033","journal-title":"Neurobiol Aging"},{"key":"5419_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40035-016-0060-6","volume":"5","author":"Q Hu","year":"2016","unstructured":"Hu Q, Wang G (2016) Mitochondrial dysfunction in Parkinson\u2019s disease. Transl Neurodegener 5:14. https:\/\/doi.org\/10.1186\/s40035-016-0060-6","journal-title":"Transl Neurodegener"},{"issue":"5\u20136","key":"5419_CR56","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbabio.2006.04.029","volume":"1757","author":"DB Zorov","year":"2006","unstructured":"Zorov DB, Juhaszova M, Sollott SJ (2006) Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta 1757(5\u20136):509\u2013517. https:\/\/doi.org\/10.1016\/j.bbabio.2006.04.029","journal-title":"Biochim Biophys Acta"},{"key":"5419_CR57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"LD Zorova","year":"2018","unstructured":"Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB, Jankauskas SS et al (2018) Mitochondrial membrane potential. Anal Biochem 552:50\u201359. https:\/\/doi.org\/10.1016\/j.ab.2017.07.009","journal-title":"Anal Biochem"},{"issue":"1","key":"5419_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-6-2","volume":"6","author":"AI Bernstein","year":"2011","unstructured":"Bernstein AI, Garrison SP, Zambetti GP, O\u2019Malley KL (2011) 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death. Mol Neurodegener 6(1):2. https:\/\/doi.org\/10.1186\/1750-1326-6-2","journal-title":"Mol Neurodegener"},{"key":"5419_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/329635","volume":"2012","author":"S Marchi","year":"2012","unstructured":"Marchi S, Giorgi C, Suski JM, Agnoletto C, Bononi A, Bonora M et al (2012) Mitochondria-ROS crosstalk in the control of cell death and aging. J Signal Transduct 2012:329635. https:\/\/doi.org\/10.1155\/2012\/329635","journal-title":"J Signal Transduct"},{"issue":"21","key":"5419_CR60","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3969\/j.issn.1673-5374.2013.21.009","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo C, Sun L, Chen X, Zhang D (2013) Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8(21):2003\u20132014. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2013.21.009","journal-title":"Neural Regen Res"},{"key":"5419_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00236","volume":"11","author":"Z Wei","year":"2018","unstructured":"Wei Z, Li X, Li X, Liu Q, Cheng Y (2018) Oxidative stress in Parkinson\u2019s disease: a systematic review and meta-analysis. Front Mol Neurosci 11:236. https:\/\/doi.org\/10.3389\/fnmol.2018.00236","journal-title":"Front Mol Neurosci"},{"key":"5419_CR62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2007.09.056","volume":"1184","author":"JG Blackinton","year":"2007","unstructured":"Blackinton JG, Anvret A, Beilina A, Olson L, Cookson MR, Galter D (2007) Expression of PINK1 mRNA in human and rodent brain and in Parkinson\u2019s disease. Brain Res 1184:10\u201316. https:\/\/doi.org\/10.1016\/j.brainres.2007.09.056","journal-title":"Brain Res"},{"issue":"Pt 7","key":"5419_CR63","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/brain\/awl114","volume":"129","author":"S Gandhi","year":"2006","unstructured":"Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, Hargreaves I et al (2006) PINK1 protein in normal human brain and Parkinson\u2019s disease. Brain 129(Pt 7):1720\u20131731. https:\/\/doi.org\/10.1093\/brain\/awl114","journal-title":"Brain"},{"key":"5419_CR64","doi-asserted-by":"publisher","unstructured":"Gegg ME, Cooper JM, Schapira AH, Taanman JW (2009) Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells. PLoS One 4(3):e4756. https:\/\/doi.org\/10.1371\/journal.pone.0004756","DOI":"10.1371\/journal.pone.0004756"},{"issue":"24","key":"5419_CR65","doi-asserted-by":"publisher","first-page":"21865","DOI":"10.1074\/jbc.M111.240242","volume":"286","author":"RJ Mailloux","year":"2011","unstructured":"Mailloux RJ, Seifert EL, Bouillaud F, Aguer C, Collins S, Harper ME (2011) Glutathionylation acts as a control switch for uncoupling proteins UCP2 and UCP3. J Biol Chem 286(24):21865\u201321875. https:\/\/doi.org\/10.1074\/jbc.M111.240242","journal-title":"J Biol Chem"},{"issue":"1","key":"5419_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/2047-9158-1-3","volume":"1","author":"PW Ho","year":"2012","unstructured":"Ho PW, Ho JW, Liu HF, So DH, Tse ZH, Chan KH et al (2012) Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson\u2019s disease. Transl Neurodegener 1(1):3. https:\/\/doi.org\/10.1186\/2047-9158-1-3","journal-title":"Transl Neurodegener"},{"issue":"4","key":"5419_CR67","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2174\/187152712800792901","volume":"11","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Zhang J, Zeng Y (2012) Overview of tyrosine hydroxylase in Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 11(4):350\u2013358. https:\/\/doi.org\/10.2174\/187152712800792901","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"4","key":"5419_CR68","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/187152712800792785","volume":"11","author":"S Tabrez","year":"2012","unstructured":"Tabrez S, Jabir NR, Shakil S, Greig NH, Alam Q, Abuzenadah AM et al (2012) A synopsis on the role of tyrosine hydroxylase in Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 11(4):395\u2013409. https:\/\/doi.org\/10.2174\/187152712800792785","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"6","key":"5419_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17060954","volume":"17","author":"M Ogino","year":"2016","unstructured":"Ogino M, Ichimura M, Nakano N, Minami A, Kitagishi Y, Matsuda S (2016) Roles of PTEN with DNA repair in Parkinson\u2019s disease. Int J Mol Sci 17(6):954. https:\/\/doi.org\/10.3390\/ijms17060954","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5419_CR70","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1083\/jcb.200611080","volume":"176","author":"SA Detmer","year":"2007","unstructured":"Detmer SA, Chan DC (2007) Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J Cell Biol 176(4):405\u2013414. https:\/\/doi.org\/10.1083\/jcb.200611080","journal-title":"J Cell Biol"},{"issue":"10","key":"5419_CR71","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2174\/092986709787846578","volume":"16","author":"LK Sharma","year":"2009","unstructured":"Sharma LK, Lu J, Bai Y (2009) Mitochondrial respiratory complex I: structure, function and implication in human diseases. Curr Med Chem 16(10):1266\u20131277. https:\/\/doi.org\/10.2174\/092986709787846578","journal-title":"Curr Med Chem"},{"issue":"3","key":"5419_CR72","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/acel.12584","volume":"16","author":"HT Kang","year":"2017","unstructured":"Kang HT, Park JT, Choi K, Choi HJC, Jung CW, Kim GR, Lee YS, Park SC (2017) Chemical screening identifies ROCK as a target for recovering mitochondrial function in Hutchinson-Gilford progeria syndrome. Aging Cell 16(3):541\u2013550. https:\/\/doi.org\/10.1111\/acel.12584","journal-title":"Aging Cell"},{"key":"5419_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.882581","volume":"10","author":"C Qu","year":"2022","unstructured":"Qu C, Yang W, Kan Y, Zuo H, Wu M, Zhang Q, Wang H, Wang D, et al. (2022) RhoA\/ROCK signaling regulates Drp1-mediated mitochondrial fission during collective cell migration. Front Cell Dev Biol 10:882581. https:\/\/doi.org\/10.3389\/fcell.2022.882581","journal-title":"Front Cell Dev Biol"},{"issue":"15","key":"5419_CR74","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.7150\/thno.96508","volume":"14","author":"J Yuan","year":"2024","unstructured":"Yuan J, Chen F, Jiang D, Xu Z, Zhang H, Jin ZB (2024) Rock inhibitor enhances mitochondrial transfer via tunneling nanotubes in retinal pigment epithelium. Theranostics 14(15):5762\u20135777. https:\/\/doi.org\/10.7150\/thno.96508","journal-title":"Theranostics"},{"issue":"2","key":"5419_CR75","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.nbd.2012.04.010","volume":"47","author":"B Villar-Cheda","year":"2012","unstructured":"Villar-Cheda B, Dominguez-Meijide A, Joglar B, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL (2012) Involvement of microglial RhoA\/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors. Neurobiol Dis 47(2):268\u2013279. https:\/\/doi.org\/10.1016\/j.nbd.2012.04.010","journal-title":"Neurobiol Dis"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05419-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:03:42Z","timestamp":1763417022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05419-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5419"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05419-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving animals were carried out in accordance with NIH guidelines and were approved by the University of Selcuk Animal Care and Use Committee (Protocol Number: 2018\u201328).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"64"}}